We are live on ! Find out more
XTNT icon

Xtant Medical Holdings
XTNT

16 hedge funds and large institutions have $61.9M invested in Xtant Medical Holdings in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

14% more funds holding

Funds holding: 14 → 16 (+2)

1.5% more ownership

Funds ownership: 83.26% → 84.77% (+1.5%)

28% less capital invested

Capital invested by funds: $85.4M → $61.9M (-$23.6M)

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.36M
2
BCM
Bridgeway Capital Management
Texas
+$334K
3
BlackRock
BlackRock
New York
+$66.5K
4
UBS Group
UBS Group
Switzerland
+$30.8K
5
Renaissance Technologies
Renaissance Technologies
New York
+$22.7K

Top Sellers

Rank Fund Capital Flow
1
BC
Bruce & Co
Illinois
-$757K
2
PCM
Perkins Capital Management
Minnesota
-$218K
3
Morgan Stanley
Morgan Stanley
New York
-$2.98K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$51.1M – – –
PWAM
2
Park West Asset Management
California
$6.99M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.05M +$2.36M +353,321 +2,238%
BC
4
Bruce & Co
Illinois
$1.01M -$757K -113,200 -38%
BCM
5
Bridgeway Capital Management
Texas
$278K +$334K +50,000 New
Renaissance Technologies
6
Renaissance Technologies
New York
$242K +$22.7K +3,400 +8%
Morgan Stanley
7
Morgan Stanley
New York
$60K -$2.98K -446 -4%
BlackRock
8
BlackRock
New York
$56K +$66.5K +9,940 +8,283%
UBS Group
9
UBS Group
Switzerland
$47K +$30.8K +4,611 +120%
Northwestern Mutual Wealth Management
10
Northwestern Mutual Wealth Management
Wisconsin
$22K +$3.79K +566 +16%
WEC
11
Winslow Evans & Crocker
Massachusetts
$8K – – –
Barclays
12
Barclays
United Kingdom
$2K +$2.61K +390 New
FHA
13
First Horizon Advisors
Tennessee
$1K – – –
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$1K – – –
VFA
15
Valeo Financial Advisors
Indiana
$1K +$608 +91 New
PCM
16
Perkins Capital Management
Minnesota
– -$218K -27,606 Closed

XTNT Hedge Fund Activity: Q2 2018 in Review

16 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q2 2018, worth a combined $61.9M — down 28% from $85.4M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new XTNT positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $2.36M. The largest seller was Bruce & Co, cutting an estimated $757K.

  • 16 institutional investors held Xtant Medical Holdings (XTNT) as of Q2 2018, up from 14 in Q1 2018.
  • Funds reported $61.9M of Xtant Medical Holdings stock for Q2 2018, down 28% quarter-over-quarter.
  • 3 funds opened new Xtant Medical Holdings positions in Q2 2018 and 1 closed out, a net change of +2 holders.
  • The largest Xtant Medical Holdings buyer in Q2 2018 was Vanguard Group, an estimated $2.36M added.
  • The largest Xtant Medical Holdings seller in Q2 2018 was Bruce & Co, an estimated $757K sold.

Based on aggregated 13F filings for Q2 2018.